Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is -45.53% vs 179.31% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is -56.86% vs 22.94% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 0.00% vs 30.00% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 48.79% vs 5.97% in Mar 2023
Compare Profit and Loss Results of Emmessar Biotech
Figures in Rs cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
0.00
2,724.00
-2,724.00
-100.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
0.00
2,724.00
-2,724.00
-100.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
26.00
-26.00
-100.00%
Raw Materials Consumed
0.00
1,476.00
-1,476.00
-100.00%
Power & Fuel Cost
0.00
222.00
-222.00
-100.00%
Employee Cost
0.00
250.00
-250.00
-100.00%
Operating Expenses
0.00
86.00
-86.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
106.00
-106.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
57.00
-57.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1.00
2,278.00
-2,277.00
-99.96%
Operating Profit (PBDIT) excl Other Income
-1.00
445.00
-446.00
-100.22%
Other Income
1.00
123.00
-122.00
-99.19%
Operating Profit (PBDIT)
0.00
569.00
-569.00
-100.00%
Interest
0.00
4.00
-4.00
-100.00%
Profit before Depriciation and Tax
0.00
565.00
-565.00
-100.00%
Depreciation
0.00
86.00
-86.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
478.00
-478.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
558.00
-558.00
-100.00%
Provision for Tax
0.00
124.00
-124.00
-100.00%
Profit After Tax
0.00
433.00
-433.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
2,063.00
-2,062.00
-99.95%
Profit Available for appropriations
2.00
2,496.00
-2,494.00
-99.92%
Appropriations
2.00
2,496.00
-2,494.00
-99.92%
Equity Dividend (%)
0%
375%
-375.00
Earnings Per Share
1.48
31.78
-30.30
-95.34%
Profit And Loss - Net Sales
Net Sales 0.56 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -45.53% vs 179.31% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.08 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -56.86% vs 22.94% in Mar 2023
Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 0.00% vs 30.00% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 0.75 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 48.79% vs 5.97% in Mar 2023